Metformin Manufacturer Copay Program: How to Pay as Little as $0

Why Metformin Rarely Needs a Traditional Copay Card

Generic metformin hydrochloride is one of the least expensive prescription medications sold in the United States. A copay card, the kind drug makers issue for brand-name products costing $500 or more per month, is unnecessary for most patients filling a generic metformin prescription. The reason is straightforward: the drug itself costs pharmacies pennies per tablet.

The American Diabetes Association (ADA) 2024 Standards of Care names metformin as the preferred first-line pharmacologic agent for type 2 diabetes, noting that "metformin has a long-standing evidence base for efficacy and safety, is inexpensive, and may reduce the risk of cardiovascular events" [1]. That phrase, "is inexpensive," separates metformin from nearly every other diabetes medication on the market.

Metformin entered the U.S. market in 1995 under the brand name Glucophage (Bristol-Myers Squibb). Generic versions became available in 2002, and today more than a dozen manufacturers produce the drug [2]. This deep generic competition is what keeps prices low. According to a 2023 analysis published in Diabetes Care, the median out-of-pocket cost for a 30-day metformin supply among commercially insured adults was $1.70, compared to $47 for a DPP-4 inhibitor and $279 for a GLP-1 receptor agonist [3]. The price difference is not small. It is enormous.

Still, some patients face higher costs. Extended-release formulations, high-dose prescriptions, and uninsured status can push monthly spending above $30. Brand-name ER versions can exceed $500. For these situations, copay programs and discount pathways exist.

Brand-Name Formulations That Still Offer Copay Assistance

Three brand-name metformin products have been marketed in the U.S.: Glucophage (immediate-release), Glucophage XR (extended-release), and Glumetza (extended-release). Glucophage and Glucophage XR are no longer actively promoted, and their manufacturer copay programs have been discontinued. Glumetza, a once-daily extended-release formulation originally developed by Depomed (now Assertio Therapeutics), has periodically offered copay cards that reduce out-of-pocket costs to as low as $0 for commercially insured patients [4].

Riomet and Riomet ER are liquid formulations of metformin designed for patients who cannot swallow tablets. These carry substantially higher list prices (sometimes exceeding $300 per month) and their manufacturer, Sun Pharmaceutical, has at various points offered patient savings programs. Verify current availability directly through Sun Pharma's patient portal or by calling the number on the Riomet prescribing information.

A critical point: manufacturer copay cards for brand-name products are not valid for patients enrolled in Medicare, Medicaid, or other federal healthcare programs. This restriction is mandated by the federal Anti-Kickback Statute [5]. If you have government insurance, skip to the Medicare and Medicaid sections below.

How to Get Generic Metformin for $4 or Less

The single fastest way to reduce your metformin cost is to fill a generic prescription at a retailer that offers a $4 generic drug list. Walmart, Sam's Club, Kroger, Costco, and several regional chains include metformin 500 mg and 850 mg immediate-release tablets on their discount programs. No insurance is required. No coupon is needed. You walk in with a prescription and pay $4 for 30 tablets or $10 for 90 tablets.

Costco does not require a membership to use its pharmacy. Federal law mandates that Costco pharmacies serve non-members, so you can access $4 generic metformin pricing without paying the annual membership fee. This is a commonly overlooked fact.

Pharmacy discount platforms provide another route. GoodRx, RxSaver, and Amazon Pharmacy consistently show generic metformin IR prices between $3 and $9 at major chains including CVS, Walgreens, and Rite Aid. Prices fluctuate by zip code and dosage form, so compare across platforms before filling. The 1000 mg tablets (the most commonly prescribed maintenance dose) tend to run $1 to $3 higher than the 500 mg strength at some pharmacies, though they remain under $15 in most markets.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) sells metformin 500 mg IR at a transparent markup over acquisition cost. As of early 2026, prices for a 90-day supply were below $5 including shipping [6]. The pharmacy ships by mail and does not accept insurance, but for uninsured patients the pricing is often the lowest available.

Insurance Coverage for Metformin in 2026

Metformin sits on Tier 1 (preferred generic) of virtually every commercial formulary in the United States. A 2022 study in The American Journal of Managed Care found that 99.6% of commercial plans and 100% of Medicare Part D plans included at least one metformin formulation on their formulary [7]. No prior authorization is required for generic metformin IR or ER in the overwhelming majority of plans.

Typical commercial insurance copays for Tier 1 generics range from $0 to $10. Many high-deductible health plans (HDHPs) with health savings accounts (HSAs) now cover preventive medications, including metformin for diabetes, before the deductible is met. The IRS expanded the list of preventive care benefits for HDHPs in 2019 to include certain chronic disease medications, and metformin for diabetes or prediabetes qualifies under this guidance [8].

If your plan has a $0 preventive drug benefit, confirm with your insurer that metformin is classified under preventive care and not standard Tier 1 coverage. The distinction matters for HDHP enrollees because preventive classification means $0 cost-sharing even before you hit your deductible.

One scenario where insurance coverage becomes complicated: brand-name extended-release formulations. If your physician writes for "Glumetza" or "Fortamet" by brand, your plan may require a prior authorization or apply Tier 3 (non-preferred brand) cost-sharing, which can exceed $75 per month. In most clinical situations, generic metformin ER is therapeutically equivalent and dramatically cheaper.

Medicare Part D and Metformin

Every Medicare Part D plan covers metformin. The 2024 CMS formulary reference file shows metformin hydrochloride IR and ER listed on 100% of standalone Part D plans and Medicare Advantage Prescription Drug plans [9]. Under the Inflation Reduction Act provisions that took effect in 2025, Medicare Part D out-of-pocket costs are capped at $2,000 per year. For a drug that costs $4 to $12 per month, this cap is irrelevant in practice, but it provides a backstop.

Most Medicare Part D plans place generic metformin on Tier 1 with copays between $0 and $5. Some plans, particularly those offering enhanced benefits, waive the copay entirely for Tier 1 diabetes medications.

Medicare beneficiaries who qualify for the Low-Income Subsidy (LIS), also called "Extra Help," pay $0 for generic metformin. The LIS program covers roughly 13 million Medicare beneficiaries [10]. Eligibility is tied to income (below 150% of the federal poverty level) and limited assets. Applications go through the Social Security Administration at ssa.gov.

Medicaid Coverage Across All 50 States

Metformin is covered by every state Medicaid program. The Medicaid Drug Rebate Program requires that participating manufacturers provide rebates on covered outpatient drugs, and metformin's extremely low base cost means negligible cost to state programs [11]. Copays for generic medications under Medicaid are capped at $4 for most beneficiaries and $0 for certain populations, including pregnant women, children under 18, and institutionalized individuals.

For patients with prediabetes, Medicaid coverage of metformin varies by state. The Diabetes Prevention Program (DPP) trial demonstrated that metformin reduced the incidence of type 2 diabetes by 31% in high-risk adults over 2.8 years (N=3,234) [12]. Despite this evidence, not all state Medicaid programs cover metformin for an off-label prediabetes indication. Check your state's preferred drug list or contact your Medicaid managed care plan directly.

Extended-Release Metformin: Where Costs Differ

Generic metformin ER tablets (the osmotic and matrix formulations) cost more than IR tablets but remain inexpensive by any measure. A 30-day supply of generic metformin ER 500 mg typically runs $8 to $15 at retail, and $15 to $30 for the 750 mg or 1000 mg ER strengths without insurance.

The FDA recalled certain lots of extended-release metformin in 2020 after testing revealed N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake limit [13]. Multiple manufacturers issued voluntary recalls, and the FDA worked with companies to resolve the contamination. By 2021, the agency confirmed that currently marketed metformin ER products met safety standards. This episode temporarily disrupted the ER supply chain and pushed some patients toward brand-name alternatives at much higher cost.

If you were switched to a brand ER product during the recall period and never switched back, ask your prescriber about returning to generic ER. The ADA's 2024 Standards note that "extended-release formulations may improve gastrointestinal tolerability," but they draw no distinction between brand and generic ER for clinical outcomes [1]. The price difference between generic ER ($10 to $30) and brand Glumetza ($400 to $700) is not justified by evidence.

Patient Assistance Programs for Uninsured and Underinsured Patients

Several nonprofit organizations provide free or reduced-cost metformin to patients who lack insurance or face financial hardship.

NeedyMeds (needymeds.org) maintains a database of patient assistance programs and discount cards. Their generic drug discount card is accepted at over 80,000 pharmacies and typically reduces generic metformin costs to $4 to $8.

RxAssist (rxassist.org) is a patient assistance program database maintained by Volunteers in Health Care. It catalogs manufacturer programs, state programs, and nonprofit assistance options searchable by drug name.

Partnership for Prescription Assistance (pparx.org) connects uninsured patients with programs from pharmaceutical manufacturers. While metformin's cost is low enough that many patients can afford it without assistance, patients taking multiple diabetes medications may benefit from enrolling in a program that covers their entire regimen.

Community health centers funded under Section 330 of the Public Health Service Act offer the 340B Drug Pricing Program, which provides outpatient drugs at significantly reduced prices [14]. If you receive care at a Federally Qualified Health Center (FQHC), your metformin may cost $0 to $2 regardless of insurance status. The Health Resources and Services Administration (HRSA) maintains a directory of 340B-eligible sites at hrsa.gov.

Off-Label Metformin for Longevity and PCOS: Coverage Gaps

Metformin is FDA-approved for type 2 diabetes. Prescriptions written for polycystic ovary syndrome (PCOS), prediabetes, or anti-aging purposes are considered off-label. Insurance coverage for off-label use is inconsistent.

For PCOS, the Endocrine Society's 2023 clinical practice guideline recommends metformin as second-line therapy for menstrual irregularity when hormonal contraceptives are contraindicated or not tolerated [15]. Many commercial insurers cover metformin for PCOS when the ICD-10 code (E28.2) appears on the claim, but some require documentation of a diabetes-related diagnosis. If your claim is denied for a PCOS indication, your prescriber can submit an appeal letter citing the Endocrine Society guideline.

The Targeting Aging with Metformin (TAME) trial, a proposed multi-site study designed to test whether metformin slows aging-related diseases, has been discussed for years but had not completed enrollment as of early 2026 [16]. No insurer covers metformin for "anti-aging" or "longevity" indications. Patients using metformin for this purpose should expect to pay cash, which, given the $4 to $12 monthly cost, remains accessible for most.

Step-by-Step: Getting the Lowest Possible Price on Metformin

First, confirm that your prescription is written for generic metformin hydrochloride (not a brand name). Second, check whether your insurance plan covers metformin as a $0 preventive medication, particularly if you have an HDHP. Third, if you are uninsured or your copay exceeds $10, compare prices on GoodRx, RxSaver, and Cost Plus Drugs before choosing a pharmacy. Fourth, if you fill at a retailer with a $4 generic list (Walmart, Kroger, Costco), you may not need a discount coupon at all.

For the extended-release formulation, the same steps apply, but expect prices $5 to $15 higher than IR at most pharmacies. If your ER prescription costs more than $20 per month without insurance, a pharmacy discount card will almost certainly bring it below that threshold.

Patients on Medicare or Medicaid should simply present their insurance card. The copay will be $0 to $5 in nearly every case. If it is higher, call your plan's pharmacy benefits line and confirm that the pharmacy is dispensing a Tier 1 generic, not a brand product.